Clin2
NCT07532356Likely a fitNot yet recruiting

Thyroid Cancer Biomarkers for Early Risk Assessment

GenomicsThyroid CancerNGS

Part of Cancer, Hormones & metabolism clinical trials.

This study combines genetic testing and urine protein analysis to help doctors better understand which newly diagnosed thyroid cancers might be more serious and need closer monitoring after treatment. By learning more about your specific cancer, the research aims to improve how doctors care for thyroid cancer patients.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 80 years
Study type
Observational

Who can take part

  • You are between 18 and 80 years old
  • You have been newly diagnosed with papillary thyroid cancer (the most common type) or have a thyroid nodule that is highly suspected to be a type of thyroid cancer
  • You have not yet had surgery to remove your thyroid
  • You are willing to provide a urine sample and allow genetic testing of your tumor tissue

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05428371Not yet recruiting
Testing cancer risk in unclear thyroid nodules

This study looks at ways to better estimate the cancer risk of thyroid nodules that are “unclear” on standard testing. It uses information from your clinical history, ultrasound findings, and additional lab/genetic-type features to help sort which nodules are more likely to be cancer.

Cagliari, CA
NCT05837260Recruiting
Tracking tumor DNA changes in advanced thyroid cancers

This study looks at a small blood test (called ctDNA) and tumor tissue to understand how advanced thyroid cancers change over time. It may help doctors better monitor cancer growth and guide treatment choices.

London
NCT06261190Enrolling by invitation
Active monitoring for low-risk thyroid cancer

This trial tests whether it is safe to avoid immediate surgery and instead monitor small thyroid cancers that are considered low-risk. If you join, doctors will check regularly to make sure the cancer does not grow or spread.

Goyang-si
NCT02747888Recruiting
Study of inherited risk for thyroid cancer

This study looks at whether thyroid cancer or thyroid lumps can run in families due to inherited (genetic) risk. It may help researchers better identify who is at higher risk and guide future screening or prevention.

Boston, Massachusetts
NCT06878534Recruiting
Thyroid cancer genetic study for patients with follicular origin

This study looks at the genes and mutations in thyroid cancers that start in follicular cells. It aims to understand how these changes relate to how aggressive the cancer is.

Naples
NCT05172921Recruiting
Study of environmental factors in thyroid cancer risk

This study looks at how environmental exposures may relate to thyroid cancer. If you have a suspicious thyroid nodule and are planning surgery, your biopsy or surgical tissue may be used to understand risk factors.

New York, New York

Hear when a new Genomics trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.